Private equity committed USD90 billion to global healthcare deals in 2022 according to Bain & Company’s 12th annual report on M&A activity. This significant capital injection – the second highest on record – shows that despite rising rates and market volatility last year, the global healthcare space is very much alive and kicking; and a further reminder of its recession-proof attributes. Rising labour costs and tighter credit conditions will require investors to perform a careful diagnosis this year, and consider creative approaches to deal making. Still, the long-term M&A outlook is likely to remain in rude health, especially in biopharma and life sciences.

Join IPEM Paris 2023 next September 19-20 in the Jardin des Tuileries
Over 4,000 delegates from 1,600 firms, including 650 LPs and 650 GPs, will be there, don’t miss the opportunity to connect with them!
Become part of the IPEM Community
We help foster and engage the Private Capital community internationally through our live and digital events. Join thousands of your peers and enjoy new connections!